Skip to main content

AGM Workshops, Symposia, and Webinars

The AGM program offers training workshops on high-throughput screening and lead discovery, as well as workshops and symposia focused on timely drug discovery and public health challenges. These workshops introduce best practices in early drug discovery and have attracted audiences from academia, government, and pharmaceutical/biotechnology laboratories. The workshops also introduce the scientific community to new technologies and provide participants with opportunities to engage with established drug discovery experts. Many of these workshops are available online for viewing on demand.

The AGM also hosts a quarterly AGM Preclinical Translational Science Webinar Series. This series highlights distinguished translational scientists who share case studies and information about preclinical translational science.


AGM Workshops on High-throughput Screening and Lead Discovery

Date(s)LocationOrganizer(s)Related Links
Feb. 4, 2024Boston, MASLAS, NCATSEvent information
Feb. 25, 2023San Diego, CASLAS, NCATSEvent information
Oct. 18-19, 2022Bethesda, MDNCATS

Event information

Videocast:   
Day 1 on Oct. 18, 2022   
Day 2 on Octr 19, 2022

Feb. 5, 2022Boston, MASLAS, NCATSEvent information and video recordings
Nov. 18-19, 2020VirtualNCATSEvent information and video recordings
Jan. 25, 2020San Diego, CASLAS, NCATS 

AGM Topic-focused Workshops

Event NameSummary/goalDatesLocationOrganizersRelated Links
Assay Guidance Workshop on Sample ManagementThis workshop aims to provide participants with fundamentals and best practices in sample management, and to introduce participants to emerging trends and technologies in sample managementOct. 26, 2023VirtualNCATS, SLAS, Vertex Pharmaceuticals

Event information

Videocast:   
Thursday, Oct. 26, 2023

Assay Guidance Workshop on 3D Tissue Models for Antiviral Drug DevelopmentThis workshop aimed to provide participants with a roadmap for developing robust and reproducible tissue models to study pandemic threat virusesJune 7-8, 2022VirtualNCATS, NIAID, Bill & Melinda Gates Foundation

Event information

Related publication

Videocast:   
Day 1 on June 7, 2022   
Day 2 on June 8, 2022

Assay Guidance Workshop for Cell-Based Assays and Lead DiscoveryThis workshop aimed to inform the translational science community on the fundamentals and applications of image-based and 3D cellular assay technologies, and to provide a future perspective on the utility of complex cellular models in drug discoveryNov. 16-17, 2021VirtualNCATS, Promega, PerkinElmer

Event information

Videocast:   
Day 1 on Nov. 16, 2021   
Day 2 on Nov. 17, 2021

Assay Guidance Workshop on DNA-Encoded Libraries (DEL) for Lead DiscoveryThis workshop aimed to inform the translational science community on the fundamentals and applications of DEL technology, and to bring together those practicing the art to share insights and perspectives in an open forumSept. 1-2, 2021VirtualNCATS, Pfizer, Nurix Therapeutics, HitGen Inc., GlaxoSmithKline

Event information

Videocast:   
Day 1 on Sept. 1, 2021   
Day 2 on Sept. 2, 2021

The Opioid Crisis and the Future of Addiction and Pain Therapeutics: Opportunities, Tools, and Technologies SymposiumThis symposium highlighted challenges and opportunities in the pre-competitive, preclinical stage of development for addiction- and pain-related medications and provided a framework for more focused efforts within the research communityFeb. 7-8, 2019NIH Campus, Bethesda, MDNCATS, NIDA, NINDS

Event information

Related publication

Videocast:   
Day 1 on Feb. 7, 2019   
Day 2 on Feb. 8, 2019

AGM Preclinical Translational Science Webinar Series

Date(s)Event NameSpeakerRelated Links
Mar. 15, 2024AI and ML in Drug DiscoveryDerek Lowe, Ph.D.Event information and video recordings
Dec. 1, 2023Preclinical Translational Science: The View from BiotechChristopher P. Austin, M.D.Event information and video recordings
Sept. 22, 2023Gene Control TherapeuticsJay Bradner, M.D.Event information and video recordings
June 2, 2023Nav1.7 as a Pain Target and Why Selective Nav1.7 Inhibitors Have Not Yet Shown Efficacy in Clinical TrialsDavid H. Hackos, Ph.D.Event information and video recordings
Mar. 10, 2023Preclinical Cancer Target Validation: How to Avoid Being Wrong (Even if You Fool Reviewer 3)William G. Kaelin, Jr., M.D.Event information and video recordings

Last updated on April 22, 2024